Hemex is a Liestal, Switzerland-based family office and life sciences funding partner focused on biotech, medical device, pharmaceutical and HealthTech companies. Its investor profile includes early- and later-stage venture relevance, including Series B context, while its official activity also supports non-dilutive European funding opportunities for healthcare startups. It is most relevant for founders in Europe seeking sector-specific capital or funding support across life sciences and medtech.